PALISADE THERAPEUTICS
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
PALISADE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2015-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.palisadetherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Gloriana Therapeutics
Gloriana Therapeutics develops first-in-class transformational therapeutics for neurological disorders.
TNeuroPharma
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.
Current Employees Featured
Founder
Investors List
SkyDeck Berkeley
SkyDeck Berkeley investment in Non Equity Assistance - Palisade Therapeutics
Official Site Inspections
http://www.palisadetherapeutics.com
Unable to get host informations!!!
More informations about "Palisade Therapeutics"
Palisade Therapeutics Company Profile 2024: Valuation, Funding ...
Palisade Therapeutics General Information Description. Provider of therapeutics based products intended to treat progressive neurological diseases. The company's products treat with a two …See details»
Palisade Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Palisade Therapeutics with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Palisade Therapeutics - Overview, News & Similar companies
Palisade Therapeutics is a company that operates in the Biotechnology industry. It employs 11-20 people and has $1M-$5M of revenue. Read More. Is this data correct? Popular Searches …See details»
Palisade Therapeutics - Company Profile - Tracxn
Oct 23, 2024 Palisade Therapeutics ranks 383rd among 424 active competitors. 149 of its competitors are funded while 74 have exited. Overall, Palisade Therapeutics and its …See details»
Palisade Therapeutics | VentureRadar
Find out more about Palisade Therapeutics including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. …See details»
Palisade Bio | Advancing Next-Generation Precision Therapies
Sep 16, 2024 Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies. Sep 16, 2024See details»
Palisade Bio, Inc. (PALI) Company Profile & Overview - Stock Analysis
Dec 27, 2024 Ticker Symbol: PALI: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001357459: CUSIP Number: 696389105: ISIN …See details»
Palisade Bio | Advancing Next-Generation Precision …
©2024 Palisade Bio. All rights reserved.See details»
Palisade Therapeutics - VentureRadar
Provider of therapeutics based products intended to treat progressive neurological diseases. The company’s therapeutics based products treat with a... ... Find out ...See details»
About Us – Overview - Palisade Bio
Our lead program, PALI-2108, is a microbiota-activated PDE4 inhibitor prodrug in development for the treatment of moderate-to-severe ulcerative colitis.See details»
Palisade Therapeutics - Contacts, Employees, Board Members
Organization. Palisade Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Palisade Bio Launches New Corporate Website and Reiterates …
PALISADE BIO, INC. New website aligns with company’s mission to become a global leader in addressing diseases linked to intestinal barrier disruption and establishing new standards of …See details»
Palisade Bio Announces Exercise of Previously Issued Warrants for …
Carlsbad, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel …See details»
Palisade Bio - Crunchbase Company Profile & Funding
Palisade Bio is a clinical-stage biopharmaceutical company developing treatments for diseases of unmet medical need. They base these treatments on sound science and therapies with a …See details»
Palisade Bio Launches New Corporate Branding and Reiterates …
Carlsbad, CA, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on …See details»
Palisade Bio Launches New Corporate Website and Reiterates …
CARLSBAD, Calif., Aug. 01, 2022 — Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) …See details»
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its
Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company …See details»
Palisade Bio | Advancing Next-Generation Precision Therapies
Sep 6, 2023 –Lead program, GT-2108 for the treatment of moderate-to-severe ulcerative colitis advancing toward completion of I ND-enabling studies with IND filing expected by Q3 2024See details»
Palisade Bio | Advancing Next-Generation Precision Therapies
Carlsbad, CA, Nov. 07, 2024 — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel …See details»
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates …
May 1, 2024 Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year end. Carlsbad, CA, May 01, 2024 — Palisade …See details»